Global Umbilical Cord Blood (UCB) Stem Cell market cagr 14.3%

Page 1


Umbilical Cord Blood (UCB) Stem

Cell Market

Umbilical Cord Blood (UCB) Stem Cell Market Scope:

Industry Analysis, Market Size, Growth, Trends Till

2031

Request Sample Report

Umbilical Cord Blood (UCB) Stem Cell Market Size and Growth

The Umbilical Cord Blood (UCB) Stem Cell market is experiencing significant growth, driven by increasing adoption for regenerative therapies and advancements in storage technologies. The global market size is projected to reach approximately $10 billion by 2026, reflecting heightened demand for UCB-derived therapies and rising awareness of their potential benefits. Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Advanced Cell Technology

◍ Athersys

◍ California Stem Cell

◍ Cytori Therapeutics

◍ Mesoblast

◍ Opexa Therapeutics

◍ Caladrius Biosciences

The Umbilical Cord Blood (UCB) Stem Cell Market is competitive, with companies like Advanced Cell Technology and Mesoblast focusing on innovative therapies. These firms use UCB stem cells for regenerative medicine, enhancing market growth. Sales figures for some include:

- Athersys: $8.7 million

- Mesoblast: $73.3 million

- Caladrius: $19.1 million.

Request Sample Report

Market Segmentation

By Application

◍ Therapeutics Service Companies

◍ Private And Government Research Institutes

◍ Academic Institutes

◍ Research Based Pharmaceutical Companies

◍ Public And Private Cord Blood Banks

◍ Others

By Product

◍ Stem Cell Transplant

◍ Autologous Transplant

◍ Allogenic Transplant

Transplant Medicine

Regenerative Medicine

Others

Request Sample Report

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.